Frequency of Hepatic Metastatic Disease in Patients with Stage IV Breast Cancer Is Similar for Steatotic and Non-Steatotic Livers
| Autor: | Adeel Haq, Tyler J Fraum, Yu Tao, Farrokh Dehdashti, Maverick LeBlanc, Mark J Hoegger, Jingqin Luo, Katherine Weilbaecher, Lindsay L Peterson |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Breast Cancer: Basic and Clinical Research, Vol 17 (2023) |
| Druh dokumentu: | article |
| ISSN: | 1178-2234 11782234 |
| DOI: | 10.1177/11782234231166476 |
| Popis: | Background: Breast cancer is the most common non-cutaneous malignancy and the second leading cause of cancer mortality in the United States. Breast cancer is a heterogeneous disease; diagnosis at an early stage renders it potentially curable, whereas advanced metastatic disease carries a worse prognosis. Objectives: To investigate whether hepatic steatosis (HS) is associated with liver metastases in patients with newly diagnosed stage IV female breast cancer patients (either de novo metastatic breast cancer or recurrent metastatic breast cancer) using non-contrast computed tomography (CT) as a marker of HS. Design: Retrospective analysis. Methods: We retrospectively identified 168 patients with stage IV breast cancer with suitable imaging from a prospectively maintained oncologic database. Three radiologists manually defined hepatic regions of interest on non-contrast CT images, and attenuation data were extracted. HS was defined as a mean attenuation |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|